ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR
2.4100
03-May-24 11:19:13
15 minutes delayed
Stocks
+0.0001
+0.00%
Today's range
2.3800 - 2.5800
ISIN
N/A
Source
NASDAQ
-
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
29 Mar 2024 09:00:00 By Nasdaq GlobeNewswire
-
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
07 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27 Feb 2024 08:00:01 By Nasdaq GlobeNewswire
-
09 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Adagene to Present at Investor and Scientific Conferences in September
07 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
31 Aug 2023 07:32:21 By Nasdaq GlobeNewswire
-
04 May 2023 09:00:01 By Nasdaq GlobeNewswire
-
Adagene Announces Updates to its Board of Directors
28 Apr 2023 07:00:11 By Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
28 Mar 2023 16:30:06 By Nasdaq GlobeNewswire
-
14 Mar 2023 18:00:00 By Nasdaq GlobeNewswire
-
Adagene Appoints Professor Aurélien Marabelle to Scientific and Strategic Advisory Board
05 Mar 2023 19:39:30 By Nasdaq GlobeNewswire
-
Adagene to Present at the Biotech Showcase™ 2023 in San Francisco on January 9
05 Jan 2023 16:01:00 By Nasdaq GlobeNewswire
-
16 Dec 2022 06:30:00 By Nasdaq GlobeNewswire
-
Adagene Appoints Cuong Do to Board of Directors and Audit Committee
21 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >